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via upregulation of adhesion molecules on the endothelium. Recent observations
suggest that reactive oxygen intermediates may play a pivotal role in TNF-a signaling
and upregulate gene expression. We therefore evaluated the effects of pyrrolidine
dithiocarbamate (PDTC; 0.1 mM) and spermine NONOate (Sper-NO; 1mM) on
adhesion molecule expression and nuclear factor kappa B (NF-kB) activation induced
by TNF-a(10 ng/ml) in cultured human pulmonary microvascular endothelial cells
(PMVEC). Treatment of cells with TNF-a for 4 h significantly induced the surface
expression of E-selectin and ICAM-1. Treatment with TNF-a for 8 h significantly
induced the surface expression of E-selectin, ICAM-1 and VCAM-1. The upregulation
of these adhesion molecules was suppressed significantly by pretreatment with PDTC
or Sper-NO for 1 h. 8-Bromo-cyclic GMP (1mM) had no such effect, suggesting that
the NO donor’s effect was non-cGMP-dependent. The mRNA expression of E-selectin,
ICAM-1 and VCAM-1, and activation of NF-kB induced by TNF-a for 2 h were
decreased significantly by the above two pretreatments. N-acetylcysteine (10mM)
and S-nitroso-N-acetylpenicillamine (1mM) had little inhibitory effects on the cell
surface and mRNA expression of these adhesion molecules stimulated by TNF-a.
Treatment with TNF-a for 4 h enhanced HL-60 leukocyte adhesion to human PMVEC,
the effect of which was inhibited significantly by pretreatment with PDTC or Sper-
NO. These findings indicate that both cell surface and mRNA expression of adhesion
molecules in human PMVEC induced by TNF-a are inhibited significantly byElsevier Ltd. All rights reserved.
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Antioxidants and NO on TNF-a-stimulated human PMVEC 581pretreatment with PDTC or Sper-NO, possibly in part through blocking the activation
of NF-kB. Although our in vitro results cannot be directly extrapolated to the in vivo
situation, they suggest a potential therapeutic approach for intervention in
cytokine-mediated inflammatory processes in the human lung.
& 2004 Elsevier Ltd. All rights reserved.Introduction
One of the proximal events in vascular inflamma-
tion is the activation of endothelial cells. The
activated endothelium expresses cell adhesion
molecules in response to a variety of pro-inflam-
matory stimuli, such as TNF-a, interleukin-1b and
lipopolysaccharide.1–3 The endothelial–leukocyte
adhesion molecules, such as E-selectin, ICAM-1
and VCAM-1, facilitate the attachment of periph-
eral blood leukocytes to the endothelial cell
surface. The regulation of adhesion molecule
expression is complex and occurs at multiple levels
ranging from gene transcription to post-transla-
tional protein modifications.
A key player in the regulation of inflammatory
gene expression is the NF-kB family of transcription
factors.2–6 The NF-kB consisting of p50 and p65
subunits is sequestered in the cytoplasm of most
cells where they are bound to inhibitory proteins
known as IkBa. Treatment of endothelial cells with
TNF-a leads to activation of IkBa kinase, which
phosphorylates IkBa and targets it for rapid poly-
ubiquitination followed by degradation through the
26S proteasome. This results in release of the NF-
kB dimer and its translocation to the nucleus to
activate transcription of multiple kB-dependent
genes, including cytokines, chemokines, adhesion
molecules, cyclooxygenase, NO synthase and IkBa.
It has been proposed that reactive oxygen inter-
mediates (ROI) are important and widely used
second messengers in NF-kB activation.3,4,6–13 NO
may also exhibit a dual redox function based on its
interaction with ROI and regulate the activation of
NF-kB.3,4,6,14–20
The human lung contains approximately 600
million alveoli surrounded by a dense meshwork
of capillaries 1500 miles long when placed end to
end. Functional impairment of the endothelial
barrier is a serious pathological condition under-
lying inflammatory lung injury.21 Expression of cell
adhesion molecules on human pulmonary micro-
vascular endothelial cells (PMVEC) is thought to
play an important role in the recruitment of
leukocytes in pulmonary inflammation. TNF-a in-
duces expression of E-selectin, ICAM-1 and VCAM-1
on the surface of human PMVEC.22,23 It has beenreported that inhibitors of phosphodiesterase 3 and
4 isoenzymes attenuate TNF-a-induced expression
of E-selectin and VCAM-1 and leukocyte adhesion to
human PMVEC,24 and that tyrosine kinase inhibitors
alter TNF-a-induced expression of ICAM-1 and
leukocyte adhesion to these cells.25 Another in
vitro study suggested that the presence of a co-
stimulus such as lipopolysaccharide is necessary for
interleukin-4 to induce effective VCAM-1 expres-
sion in human PMVEC.22 Furthermore, in vivo
studies have demonstrated that NF-kB activation
in the lung is suppressed by antioxidants or anti-
inflammatory cytokines.7,8,26
In humans, an imbalance between the production
of ROI and antioxidant capacity can lead to a state
of ‘‘oxidative stress’’ that contributes to the
pathogenesis of a number of pulmonary diseases,
such as acute respiratory distress syndrome, inter-
stitial pulmonary diseases, emphysema, bronchial
asthma and brochopulmonary dysplasia.4,21,27 Pre-
vious studies have reported high levels of expres-
sion of NF-kB in airway cells of asthmatic
patients.28,29 Thus, increased NF-kB expression
and DNA binding may underlie the increased
expression of several inflammatory proteins in the
asthmatic airway.
Much of the extensive work, to date, examining
the redox mechanisms by which cytokines or
lipopolysaccharide induce cell adhesion molecules
and factors that control these processes has been
carried out using endothelial cells derived from
large vessels.9,11–14,18,19 There is evidence, how-
ever, for heterogeneity of endothelial cells be-
tween different vascular sites.1 Thus, it may be
necessary to use endothelial cells derived from the
microvasculature of the lung in in vitro studies that
seek to examine the signaling mechanisms of
inflammatory conditions within this organ. The
purpose of the present study was to test the
hypothesis that TNF-a induces cell adhesion mole-
cule expression through a redox-sensitive pathway
in human PMVEC. We examined the effects of
antioxidants and exogenous NO on the induction of
adhesion molecules, including E-selectin, ICAM-1
and VCAM-1, and the consequent adhesion of
leukocytes, after TNF-a-stimulation of human
PMVEC in vitro.
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Endothelial cell line
Human PMVEC (Applied Cell Biology Research
Institute, Kirkland, WA) were cultured in M199
medium (Sigma, St. Louis, MO) containing 20% fetal
bovine serum (Sigma), 30 mg/ml endothelial cell
growth factor (Biomedical Technologies, Stought-
on, MA) and 100 mg/ml heparin (Aventis Pharma,
Tokyo, Japan) using T-25 flasks (Becton Dickinson,
Franklin Lakes, NJ) precoated with 10 mg/ml human
fibronectin (Sigma) in a humidified atmosphere of
5% CO2 at 37 1C. The cells were confirmed to be
endothelial in origin based on distinct cobblestone
morphological features and positive immunofluor-
escent labeling with factor VIII, acetylated low-
density lipoprotein and diaminofluorescein-2 (Daii-
chikagaku, Tokyo), as described previously.30
Human promyelocytic leukemic cell line
(HL-60)
HL-60 cells (Applied Cell Biology Research Institute)
were grown in RPMI 1640 medium (Sigma) contain-
ing 5% fetal bovine serum using T-25 flasks
and maintained in log phase growth (about
5 105 cells/ml).
Flow cytometry analysis
Indirect immunofluorescence using flow cytometry
analyzed cell surface expression of adhesion mole-
cules in human PMVEC. After cells reached con-
fluence in T-25 flasks, they were incubated for 4 h in
M199 medium containing 0.5% human albumin
(Nacalai, Kyoto, Japan) alone or together with
10 ng/ml TNF-a (Sigma). In other flasks, human
PMVEC were pretreated for 1 h in M199 medium
containing 0.5% human albumin with 0.1mM pyrro-
lidine dithiocarbamate (PDTC), 10mM N-acetylcys-
teine (NAC) (Sigma), 1mM spermine NONOate
(Sper-NO), 1mM S-nitroso-N-acetylpenicillamine
(SNAP) (Cayman) or 1mM 8-bromo-cyclic GMP (8-
Br-cGMP) (Sigma); then they were incubated in the
same medium alone or with 10 ng/ml TNF-a for 4 h.
In other independent experiments, we also per-
formed eight-hour-treatment with TNF-a and ex-
amined the effects of PDTC or Sper-NO. Viability of
endothelial cells was unaffected during the time
course of these experiments, as assessed by the
trypan blue test. After completion of the treat-
ment, cells were washed twice with phosphate-
buffered saline (PBS), detached by incubation with
0.02% EDTA, fixed with 3.7% formaldehyde in PBSfor 10min at 4 1C and washed twice with PBS
containing 0.2% human albumin. Cells were incu-
bated for 45min at 4 1C with 2 mg/ml mouse anti-
human monoclonal antibodies against E-selectin,
ICAM-1, VCAM-1 or IgG1 isotype control (PharMin-
gen, San Diego, CA) in PBS containing 1mg/ml
human IgG (Mitsubishi Pharma, Osaka, Japan),
washed twice with PBS containing 0.2% albumin
and then incubated with a 1:200 dilution of goat
anti-mouse IgG conjugated with fluorescein iso-
thiocyanate (Tagoimmunologicals, Camarillo, CA)
for 30min at 4 1C. Following two final washes in PBS
containing 0.2% albumin, samples were assayed
using the Coulter Epics XL flow cytometer (Miami,
FL). At least 5000 events were collected for
each sample; the results were expressed as
mean fluorescence intensity as calculated on a
logarithmic scale.Quantitative real-time RT-PCR analysis
The mRNA expression of adhesion molecules was
studied with quantitative real-time RT-PCR. After
cells reached confluence in T-25 flasks, they were
incubated for 2 h in M199 medium containing 0.5%
human albumin alone or together with 10 ng/ml
TNF-a. In other flasks, cells were pretreated for 1 h
in M199 medium containing 0.5% human albumin
with 0.1 mM PDTC, 10mM NAC, 1mM Sper-NO or
1mM SNAP; they were then incubated in the same
medium alone or with 10 ng/ml TNF-a for 2 h. After
completion of the treatment, total RNA was
extracted from cells using the RNeasy Kit (Qiagen,
Tokyo). First-strand cDNA synthesis was performed
in a 20-ml reaction volume containing 1 mg of total
RNA, 0.5 mM oligo(dT)18, 20U RNase inhibitor, 100 U
murine leukemia virus reverse transcriptase (Toyo-
bo, Osaka) and 1mM of each dNTP. The reaction
was performed for 50min at 42 1C, and then for
5min at 99 1C to inactivate the reverse transcrip-
tase. Real-time PCR experiments were conducted
in the LightCycler system (Roche Diagnostics, Idaho
Falls, ID). Amplification was performed in duplicate
in a 20-ml reaction volume containing 2 ml of
10 LightCycler DNA Master SYBR Green I (contain-
ing 10 PCR buffer, dNTP mixture, 10mM MgCl2,
SYBR Green I dye and Taq DNA polymerase), 1.6 ml
of 25mM MgCl2 (final concentration 3mM), 2 ml of
cDNA (or water as negative control, which was
always included) and 0.5 mM (final concentration) of
each primer. The LightCycler quantified b-actin
mRNA as an internal control for normalization of
adhesion molecule mRNA values. Table 1 lists the
primers for E-selectin, ICAM-1, VCAM-1 and b-actin
(Nihon Gene Research Laboratories, Miyagi, Japan).
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Table 1 List of oligonucleotides used for E-selectin, ICAM-1, VCAM-1 and b-actin cDNA amplification.
Target gene Sequence Length Position (bp) Annealing Temperature (1C)
E-selectin S TGTGAAGCTCCCACTGAGT 19-mer 1755–2042 (307) 54.1
AS TCTGGCATAGTAGGCAAGAA 20-mer
ICAM-1 S TAGAGACCCCGTTGCCTAA 19-mer 191–389 (217) 55.0
AS GTAAGGTTCTTGCCCACTG 19-mer
VCAM-1 S GGGAACGAACACTCTTACCT 20-mer 262–482 (240) 52.9
AS ATCCTCCAGAAATTCCTGAC 20-mer
b-actin S ACATCCGCAAAGACCTGT 18-mer 904–1313 (427) 54.9
AS CCTTCACCGTTCCAGTTT 18-mer
S=sense, AS=antisense.
Antioxidants and NO on TNF-a-stimulated human PMVEC 583Real-time PCR was performed in glass capillaries
with an initial denaturation step by heating at
20 1C/s (temperature transition) to 95 1C for 10min,
followed by 40 cycles of three steps, consisting of
heating at 20 1C/s to 95 1C with a 15-s hold, cooling
at 20 1C/s to 55 1C with a 5-s hold, and heating at
20 1C/s to 72 1C with a 18-s hold. After amplifica-
tion, a melting curve was obtained by heating at
20 1C/s to 95 1C with a 0-s hold, cooling at 20 1C/s to
60 1C with a 15-s hold, and slowly heating at 0.1 1C/s
to 95 1C with a 0-s hold for fluorescence collection.
Melting peaks were used to determine the specifi-
city of the PCR reaction. Standard curves were
generated using 10-fold serial dilutions
(103–101 ng/20 ml) of total RNA extracted from
TNF-a-treated cells. For data analysis, the fit-point
method was used to set the threshold between
background and significant fluorescence. A stan-
dard curve was generated from plotting external
standard concentrations against threshold cycle.
The specificity of the PCR reaction was verified by
agarose gel electrophoresis and ethidium bromide
staining. The results were obtained from four
independent experiments.Quantification of NF-jB activity in the
nucleus and cytoplasm by
immunofluorescence
Human PMVEC were grown on glass bottom culture
dishes (MatTek Corporation, Ashland, MA). Cells
were treated as described in Quantitative real-
time RT-PCR analysis, in which the experiments
with NAC and SNAP were abridged. Thereafter, the
endothelial cells were washed three times with PBS
and then fixed and permeabilized with 20 1C
acetone for 2min. They were washed three times
with PBS, treated with 10% normal goat serum(Vector Laboratories, Burlingame, CA) for 20min
and then incubated with 0.2 mg/ml rabbit poly-
clonal antibody directed against the NF-kB subunit
p65 (Santa Cruz Biotechnology, Santa Cruz, CA) for
1 h. After three washes with PBS, 1.0 mg/ml
biotinylated goat anti-rabbit antibody (Vector
Laboratories) was applied to the cells for 45min.
Following three washes with PBS, 1.0 mg/ml strep-
tavidin–fluorescein isothiocyanate (Vector Labora-
tories) was added for 30min. After washing three
times with PBS, immunofluorescence was visualized
using an IX70 inverted microscope (Olympus,
Tokyo). Cell images were captured and quantified
using FISH imaging software (Hamamatsu Photo-
nics, Shizuoka, Japan) and Lumina Vision fluores-
cence imaging analysis software (Mitani, Tokyo).
The fluorescence intensity for NF-kB p65 in the
nucleus and cytoplasm was measured in 20 cells
that were randomly chosen for each experiment.
Subsequently, the ratio of nuclear/cytoplasmic NF-
kB p65 fluorescence intensity was calculated. The
results were based on three independent experi-
mental conditions.Adhesion assay
Two-hundred microlitres of endothelial cell suspen-
sion (5 104 cells/well) were seeded on 48-well
culture plates (Becton Dickinson) and allowed to
grow to confluence. Cells were treated as described
in Flow cytometry analysis, in which the
experiment with 8-bromo-cyclic GMP was abridged.
HL-60 cells were labeled with 3 mM 5-chloromethyl-
fluorescein diacetate (Molecular Probes, Eugene,
OR) for 45min at 37 1C in calcium-free Hanks’
buffered saline solution (Sigma) and subsequently
washed twice with the same buffer. Fluorescence-
labeled cells (3 105 cells/ml) were resuspended in
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min. Human PMVEC were washed three times with
the same buffer, and 200 ml of labeled HL-60 cells
(6 104/well) were plated on the endothelial
monolayers. After incubation for 15min at 37 1C,
non-adherent HL-60 cells were collected by aspira-
tion of the HL-60 suspension buffer and subsequent
draining with 200 ml of the same buffer (in a final
volume of 400 ml). Thereafter, 400 ml of Krebs–Rin-
ger buffer containing 0.5% albumin were placed
into each well. Both adherent and non-adherent
HL-60 cells were lysed with the addition of 200 ml of
6% Triton X-100 (Nacalai) in PBS for 2 h at 37 1C.
Fluorescence was measured using a spectrofluo-
rometer (Fluoroskan II, Thermo Labsystems, Van-
taa, Finland) with excitation at 485 nm and
emission at 538 nm. The percentage of HL-60
adhesion was calculated by dividing the fluores-
cence for adherent cells by that for both adherent
and non-adherent cells. The results were based on
two experimental conditions, each consisting of six
replicates.
Adhesion blockade by specific monoclonal anti-
bodies was performed to determine the contribu-
tion of E-selectin, ICAM-1 and VCAM-1 to the HL-60
cell adhesion to TNF-a-treated human PMVEC.
After stimulation of endothelial cells with 10 ng/
ml TNF-a for 4 h and three washes with Krebs–Rin-
ger buffer containing 0.5% albumin, saturating
amounts of mouse monoclonal antibodies directed
against the adhesion molecules were applied to the
cells for 1 h. The blocking concentration was 40 mg/
ml for anti-human E-selectin antibody, 20 mg/ml for
anti-human ICAM-1 antibody and 60 mg/ml for anti-
human VCAM-1 antibody (R&D systems, Minneapo-
lis, MN). Mouse IgG1 isotype control (R&D systems)
was applied to the cells in other wells; the
concentration was adjusted in accordance with
that for different blocking antibodies. After aspir-
ating the medium, the fluorescence-labeled HL-60
cells were plated on the endothelial cells, incu-
bated for 15min, and then the percentage of HL-60
adhesion was calculated, as outlined above. The
results were based on two experimental conditions,
each consisting of six replicates.Statistical analysis
Values were expressed as the mean7SEM. Differ-
ences between groups were examined for statis-
tical significance using the paired t-test or one-way
analysis of variance followed by Scheffe’s test as
appropriate. P valueso0.05 were considered sta-
tistically significant.Results
Effects of antioxidants, NO donors and a
cyclic GMP analogue on cell surface
expression of adhesion molecules induced by
TNF-a
As shown in Fig. 1, treatment of human PMVEC with
TNF-a for 4 h resulted in a significant increase in the
surface expression of E-selectin and ICAM-1, but
not of VCAM-1, compared with the non-stimulated
cells. Pretreatment for 1 h with PDTC or Sper-NO
significantly inhibited the TNF-a-induced expres-
sion of E-selectin (mean fluorescence intensity: by
28%, 39%, respectively) and ICAM-1 (by 44%, 55%,
respectively) on endothelial cell surfaces (Fig. 1A
and C). NAC or SNAP tended to inhibit the TNF-a-
induced expression of ICAM-1 (by 27%, 22%,
respectively), albeit not statistically significant
(Fig. 1B and D). 8-Bromo-cGMP had no effect on
the TNF-a-induced expression of any adhesion
molecules (Fig. 1E). Eight-hour-treatment with
TNF-a caused a significant increase in the
surface expression of E-selectin, ICAM-1 and
VCAM-1 (Fig. 2). Their respective effects were
inhibited significantly by pretreatment with PDTC
(Fig. 2A) or Sper-NO (Fig. 2B) for 1 h. Treatment of
endothelial cells with PDTC, NAC, Sper-NO, SNAP or
8-Br-cGMP alone did not alter the expression of any
adhesion molecules.Effects of antioxidants and NO donors on
mRNA expression of adhesion molecules
induced by TNF-a
As shown in Fig. 3, treatment of human PMVEC with
TNF-a for 2 h caused a significant increase in the
mRNA level of E-selectin, ICAM-1 and VCAM-1, as
compared to the non-stimulated cells. Pretreat-
ment for 1 h with PDTC (Fig. 3A) or Sper-NO
(Fig. 3C) significantly inhibited the TNF-a-induced
mRNA expression of E-selectin (mean level: by 83%,
80%, respectively), ICAM-1 (by 70%, 76%, respec-
tively) and VCAM-1 (by 90%, 89%, respectively).
NAC tended to inhibit the TNF-a-induced mRNA
expression of E-selectin (by 39%) and VCAM-1 (by
42%), but the differences were not statistically
significant (Fig. 3B). SNAP also tended to inhibit the
TNF-a-induced mRNA expression of E-selectin (by
27%), ICAM-1 (by 27%) and VCAM-1 (by 48%), but the
difference reached statistical significance only for
VCAM-1 (Fig. 3D). Treatment with PDTC, NAC, Sper-
NO or SNAP alone did not alter the mRNA level of
any adhesion molecules.
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Figure 1 Effects of antioxidants, NO donors and a cyclic GMP analogue on the cell surface expression of E-selectin,
ICAM-1 and VCAM-1 in human PMVEC stimulated by TNF-a for 4 h. Cells were without pretreatment or pretreated with
antioxidants (0.1mM PDTC, 10mM NAC), NO donors (1mM Sper-NO, 1mM SNAP) or a cyclic GMP analogue (1mM 8-Br-
cGMP) for 1 h and then not stimulated or stimulated with TNF-a (10 ng/ml) for 4 h. The Nil group consisted of cells
incubated with medium alone. These cells were immunostained with specific antibodies against adhesion molecules and
analyzed by flow cytometry. Immunostaining with isotype-matched IgG1 served as internal control. Results are
expressed as the mean7SEM of four or five independent experiments. *Po0.05, **Po0.005, ***Po0.001 vs. Nil; #Po0.05,
##Po0.005, ###Po0.001 vs. TNF-a alone.
Antioxidants and NO on TNF-a-stimulated human PMVEC 585Effects of antioxidants and NO donors on
the TNF-a-induced nuclear translocation of
NF-jB
As shown in Fig. 4, non-stimulated human PMVEC
revealed a diffuse distribution of immunoreactive
NF-kB p65 within the cytoplasm (Fig. 4A). In
contrast, treatment with TNF-a for 2 h resulted in
dense accumulation of immunoreactive NF-kB p65
within the nucleus (Fig. 4B). This effect was
inhibited by pretreatment with PDTC (Fig. 4C) or
Sper-NO for 1 h (Fig. 4D). Accordingly, the TNF-a-
induced high ratio of nuclear/cytoplasmic NF-kB
p65 fluorescence was decreased significantly in
endothelial cells pretreated with these chemicals
than in non-pretreated cells (Fig. 5). Pretreatment
with PDTC or Sper-NO alone had no effect (data not
shown).Effects of antioxidants and NO donors on
HL-60 cell adhesion to TNF-a-stimulated cells
As shown in Fig. 6, stimulation with TNF-a for 4 h
significantly enhanced the HL-60 cell adhesion to
human PMVEC. Pretreatment of endothelial cells
with PDTC (Fig. 6A) or Sper-NO (Fig. 6C) for 1 h
caused significant inhibition of the TNF-a-induced
adhesion, while NAC (Fig. 6B) or SNAP (Fig. 6D) had
no such effect. Pretreatment with PDTC, NAC,
Sper-NO or SNAP alone had no effect. The enhanced
HL-60 cell adhesion to TNF-a-stimulated cells was
abolished by pretreatment with anti-E-selectin
antibody before the adhesion assay (Fig. 7A), while
pretreatment with anti-ICAM-1 (Fig. 7B) or anti-
VCAM-1 antibodies had no such effect (Fig. 7C).
Isotype-matched control antibody did not affect
the HL-60 cell adhesion.
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Figure 2 Effects of PDTC and Sper-NO on the cell surface
expression of E-selectin, ICAM-1 and VCAM-1 in human
PMVEC stimulated by TNF-a for 8 h. Cells were without
pretreatment or pretreated with 0.1mM PDTC or 1 mM
Sper-NO for 1 h and then not stimulated or stimulated
with TNF-a (10 ng/ml) for 8 h. The Nil group consisted of
cells incubated with medium alone. These cells were
immunostained with specific antibodies against adhesion
molecules and analyzed by flow cytometry. Immunostain-
ing with isotype-matched IgG1 served as internal control.
Results are expressed as the mean7SEM of three
independent experiments. *Po0.001 vs. Nil; #Po0.001
vs. TNF-a alone.
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Positioned at the interface between blood and
tissue, the endothelium is equipped to respond
quickly to local changes in biological needs caused
by inflammation. Endothelial cells express cell
adhesion molecules that orchestrate the trafficking
of circulating blood cells.1–3 These adhesion mole-
cules accelerate the migration of leukocytes
toward sites of inflammation in response to a
variety of stimuli. The TNF-a-induced upregulation
of endothelial–leukocyte adhesion molecules and
consequent leukocyte adhesion have been well
documented to occur in vivo as well as in
vitro.1,2,6,7,9,11–14,16,22–25 However, little informa-
tion is yet available as to redox mechanisms in the
adhesion molecule expression in human PMVEC.7Present experiments using cultured human
PMVEC demonstrated that cell surface expression
of E-selectin, ICAM-1 and VCAM-1 were induced
significantly after stimulation with TNF-a for 8 h,
but that the expression of VCAM-1 did not
increase significantly after 4-h treatment with
TNF-a. Treatment of endothelial cells with TNF-a
for 2 h also induced a significant increase
in the mRNA level of E-selectin, ICAM-1 and
VCAM-1. Preliminary experiments indicated
that cell surface expression of ICAM-1 and VCAM-1
was markedly induced after stimulation with
TNF-a (10 ng/ml) for 24 h. The mean (7SEM)
fluorescence intensity was 1.470.2 and 2.270.3
for E-selectin, 2.670.4 and 76.073.1 for ICAM-1,
and 1.470.2 and 17.173.6 for VCAM-1 in non-
stimulated and TNF-a-stimulated cells, respectively
(n ¼ 4 in each) (MZ Jiang and H Tsukahara,
unpublished observations). In support of this,
Blease et al.22 have revealed that TNF-a induces
maximal E-selectin expression at 6 h that is reduced
at 16 h, and also significant ICAM-1 expression at 6 h
and maximal expression at 24 h, while TNF-a-
induced VCAM-1 expression peaks at 24 h that are
sustained at 72 h. It appears, therefore, that the
time-dependent kinetics of adhesion molecule
expression are diversified in TNF-a-stimulated hu-
man PMVEC.
Regulation of adhesion molecule expression is
under the control of the endothelial NF-kB
system.2,3,5,6 Analysis of promoter elements of
adhesion molecule genes has revealed that E-
selectin, ICAM-1 and VCAM-1 contain from one to
three NF-kB binding sites. Activation of this
transcription factor involves phosphorylation of
the main inhibitory protein IkBa followed by
dissociation of NF-kB from IkBa and degradation
of IkBa. NF-kB then moves to the nucleus and
activates the expression of a plethora of genes. The
activation pathway is widespread and possibly
ubiquitous in vascular endothelial cells.9,11–14,31
This is consistent with our finding that stimulation
by TNF-a for 2 h caused the translocation of NF-kB
p65 to the nucleus in human PMVEC. The functional
significance of the adhesion molecules induced by
TNF-a was evaluated with a static adhesion assay
using the promyelocytic leukemic cell line HL-60.
As expected, treatment with TNF-a for 4 h stimu-
lated endothelial cells to increase the HL-60
binding. Monoclonal antibody against E-selectin,
but not ICAM-1 or VCAM-1, abolished the HL-60
adhesion to TNF-a-stimulated cells, which indi-
cated the major contribution of E-selectin to the
adhesion process of HL-60 to TNF-a-stimulated
endothelial cells under these experimental
conditions.
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Figure 3 Effects of antioxidants and NO donors on the mRNA expression of E-selectin, ICAM-1 and VCAM-1 in TNF-a-
stimulated human PMVEC. Cells were without pretreatment or pretreated with antioxidants (0.1mM PDTC, 10mM NAC)
or NO donors (1mM Sper-NO, 1mM SNAP) for 1 h and then not stimulated or stimulated with TNF-a (10 ng/ml) for 2 h.
The Nil group consisted of cells incubated with medium alone. The mRNA levels of adhesion molecules were determined
by quantitative real-time PCR analysis. Data indicate specific PCR products expressed as a percentage relative to b-
actin mRNA and represent the mean7SEM of four independent experiments. *Po0.05, **Po0.01, ***Po0.005,
****Po0.001 vs. Nil; #Po0.05, ##Po0.001 vs. TNF-a alone.
Figure 4 Effects of PDTC and Sper-NO on the nuclear
translocation of NF-kB p65 in TNF-a-stimulated human
PMVEC. Cells were without pretreatment or pretreated
with 0.1mM PDTC or 1mM Sper-NO for 1 h and then not
stimulated or stimulated with TNF-a (10 ng/ml) for 2 h.
The NF-kB subunit p65 was immunostained with the
specific antibody and visualized as detailed in Methods.
Representative immunofluorescence studies are shown.
(A) unstimulated cells; (B) TNF-a-stimulated cells; (C)
and (D) cells pretreated with PDTC (C) or Sper-NO (D) and
then stimulated by TNF-a.
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Figure 5 Effects of PDTC and Sper-NO on the TNF-a-
induced high ratio of nuclear/cytoplasmic NF-kB p65
fluorescence in human PMVEC. Cells were without
pretreatment or pretreated with 0.1mM PDTC or 1 mM
Sper-NO for 1 h and then not stimulated or stimulated
with TNF-a (10 ng/ml) for 2 h. The NF-kB subunit p65 was
immunostained with the specific antibody and the
fluorescence intensity was quantified as detailed in
Methods. Results are expressed as the mean7SEM of
three independent experiments (20 cells for each
experiment). *Po0.001 vs. non-treatment (medium
alone); #Po0.001 vs. treatment with TNF-a alone.
Antioxidants and NO on TNF-a-stimulated human PMVEC 587TNF-a stimulates production of ROI, including
superoxide anions, hydrogen peroxide and hydroxyl
radicals, in a variety of cell types.9,12,13 ROI
generated in excess amounts damage cells by
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Figure 6 Effects of antioxidants and NO donors on HL-60 cell adhesion to TNF-a-stimulated human PMVEC. Cells were
without pretreatment or pretreated with antioxidants (0.1mM PDTC, 10mM NAC) or NO donors (1mM Sper-NO, 1mM
SNAP) for 1 h and then not stimulated or stimulated with TNF-a (10 ng/ml) for 4 h. Fluorescence-labeled HL 60 cells
were added to endothelial cells as suspension, co-incubated for 15min and the percentage of HL-60 adhesion was
calculated. Results are expressed as the mean7SEM of two independent experiments, each consisting of six replicates.
*Po0.001 vs. non-treatment (medium alone); #Po0.005, ##Po0.001 vs. TNF-a alone.
M.-Z. Jiang et al.588peroxidizing lipids and disrupting proteins and
nucleic acids. ROI in lower concentrations may
function as second messengers in mediating
TNF-a- and interleukin-1b-activated signal trans-
duction pathways that regulate the NF-kB
system.3,6 Because the nuclear translocation of
NF-kB is essential for the regulation of adhesion
molecules in cytokine-activated endothelial
cells,9,11–14,31 it is plausible that there would be a
common redox-sensitive mechanism controlling the
expression of E-selectin, ICAM-1 and VCAM-1 in
these cells.
Based on the above considerations, we tested the
impact of two antioxidants, PDTC and NAC, and two
NO donors, Sper-NO and SNAP, on TNF-a-induced
expression of adhesion molecules in human PMVEC.
The antioxidants, PDTC and NAC, are structurally
different but both prevent NF-kB activation
through their antioxidant property.7–13 Marui et
al.11 and Weber et al.13 reported that PDTC or NAC
inhibited TNF-a-induced VCAM-1 surface protein
and mRNA expression, in part, by blocking NF-kBactivation in human umbilical vein endothelial
cells. Ferran et al.9 reported that stimulation of
porcine aortic endothelial cells with TNF-a resulted
in ROI production and that pretreatment with PDTC
inhibited TNF-a-induced generation of ROI, activa-
tion of NF-kB and expression of E-selectin, ICAM-1
and VCAM-1. Rahman et al.12 also demonstrated
that stimulation of human pulmonary artery en-
dothelial cells with TNF-a resulted in ROI produc-
tion and that pretreatment with PDTC or NAC
inhibited TNF-a-induced generation of ROI, and
activation of NF-kB and E-selectin expression.
These results support the contention that genera-
tion of ROI in endothelial cells induced by pro-
inflammatory cytokines such as TNF-a is a critical
signal mediating cell adhesion molecule expression.
Activation of NF-kB DNA binding activity was also
inhibited by treatment with NO donors in
studies using vascular endothelial cells. Liao and
associates18,19 showed that NO donors, sodium
nitroprusside and S-nitrosoglutathione, inhibited
TNF-a-induced NF-kB activation by stabilization
ARTICLE IN PRESS
0
10
20
30
40
50
TNF
Control IgG1
Anti-E-selectin
H
L-
60
 ad
he
sio
n 
(%
)
*
*
#
0
10
20
30
40
50
TNF
Control IgG1
Anti-ICAM-1
H
L-
60
 ad
he
sio
n 
(%
) * *
*
-0
10
20
30
40
50
TNF
Control IgG1
Anti-VCAM-1
H
L-
60
 ad
he
sio
n 
(%
) * * *
(A) (B)
(C)
- +
-
-
-
- -
-
+
+
+
+
- +
-
-
-
- -
-
+
+
+
+
- +
-
-
-
- -
-
+
+
+
+
Figure 7 Effects of specific monoclonal antibodies against E-selectin, ICAM-1 and VCAM-1 on HL-60 cell adhesion to
TNF-a-treated human PMVEC. After stimulation with TNF-a (10 ng/ml) for 4 h, endothelial cells were incubated with
blocking monoclonal antibodies against E-selectin, ICAM-1, VCAM-1 or control isotype-matched IgG1. Thereafter,
fluorescence-labeled HL-60 cells were plated on endothelial cells, incubated for 15min and the percentage of HL-60
adhesion was calculated. The Nil group consisted of cells incubated with medium alone. Results are expressed as the
mean7SEM of two independent experiments, each consisting of six replicates. *Po0.001 vs. non-treatment (medium
alone); #Po0.001 vs. TNF-a alone.
Antioxidants and NO on TNF-a-stimulated human PMVEC 589and transcriptional induction of IkBa in human
saphenous vein endothelial cells, and that macro-
phage-derived inducible NO also attenuated VCAM-
1 gene expression in the same cells, in part, by the
inhibitory effect of NO on kB cis-acting elements.
They also reported that the same NO donors
inhibited cytokine (TNF-a, interleukin-1b)-induced
adhesion molecule (E-selectin, ICAM-1, VCAM-1)
expression, in part, by blocking NF-kB activation in
human saphenous vein endothelial cells, and that
this inhibition was unaffected by cGMP analogues
and paralleled by reduced monocyte adhesion to
endothelial monolayers.14 Khan et al.31 showed
that in human umbilical vein endothelial cells and
dermal microvascular endothelial cells, an NO
donor (diethyl-amine-NO) reduced NF-kB activation
and VCAM-1 expression at the cell surface and
mRNA levels induced by TNF-a. Therefore, it was
expected that antioxidants or NO donors would
limit the TNF-a-induced activation of NF-kB and
resultant expression of cell adhesion molecules in
human PMVEC.In the present experiments, pretreatment with
PDTC or Sper-NO significantly decreased the level
of NF-kB p65 presented in the nucleus of TNF-a-
stimulated human PMVEC compared to cells treated
with TNF-a alone. Our results indicate the inhibi-
tory effect of these agents on TNF-a-induced NF-kB
activation in human PMVEC. We also assessed the
inhibitory effect of PDTC or Sper-NO on TNF-a-
induced adhesion molecule expression in these
cells. PDTC and Sper-NO significantly decreased
the mRNA level of E-selectin, ICAM-1 and VCAM-1
induced by treatment with TNF-a for 2 h. They also
significantly suppressed the surface expression of
the adhesion molecules induced by treatment with
TNF-a for periods of 4 or 8 h. NAC and SNAP also
tended to reduce the level of mRNA and surface
expression of some adhesion molecules, but their
inhibitory effect did not reach statistical signifi-
cance except for the effect of SNAP on the VCAM-1
mRNA level. NAC is an antioxidant that can increase
the intracellular concentration of glutathione and
augment cellular antioxidant capacity and can also
ARTICLE IN PRESS
M.-Z. Jiang et al.590directly scavenge ROI. PDTC has a radical-scaven-
ging, antioxidant property and also a metal-
chelating property that decreases oxidative stress
by preventing formation of hydroxyl radicals from
hydrogen peroxide via the Fenton reaction.32,33 We
assume that the more potent effect of PDTC than
NAC may be related to its metal-chelating property,
which may be independent of the effect on the
cellular redox state. The more potent effect of
Sper-NO than SNAP could be the result of the higher
dose of NO released from Sper-NO than SNAP during
the experiments because their reported half-lives
at pH 7.4 are 39min and a few hours, respec-
tively.34–36 It is interesting to note that PDTC and
Sper-NO suppress the TNF-a-induced cell surface
and mRNA expression of adhesion molecules in a
most profound way, whereas the inhibition of NF-kB
nuclear translocation is much less profound.
It is possible that the other redox-sensitive
transcription factors, such as activator protein-1,
are involved in the upregulation of adhesion
molecules.4 The effects of antioxidants and
NO on the other transcription factors in
TNF-a-stimulated human PMVEC will be investi-
gated in the future.
It is well known that NO activates soluble
guanylate cyclase to generate cGMP, which alters
contractile responses of cells.15 However, the
addition of a cell membrane-permeable analogue
of cGMP, 8-Br-cGMP, did not affect the adhesion
molecule expression in our cell culture, suggesting
that the NO effect is independent of cGMP
formation. NO may offer similar mechanisms to
those of antioxidants in terms of suppressing ROI
production and inhibiting NF-kB because NO can
bind the superoxide anion with extremely high
affinity and thereby decrease its dismutated
product, hydrogen peroxide.3,14,15,18,31 Alterna-
tively, NO may directly affect protein kinases
and/or phosphatases that regulate IkBa phosphor-
ylation18 or S-nitrosylate a critical thiol in the DNA-
interacting NF-kB p50 subunit.17 One attractive
speculation is that inducible-type NO synthase
expression by macrophages and vascular smooth
and endothelial cells would produce relatively
large amounts of NO, implicating an auto-protec-
tive regulatory mechanism because the induction
of NO synthase in these cells requires activation of
NF-kB.15,19,20 An additional notable role of NO is
that this molecule may regulate the cell–matrix
and/or cell–cell adhesion and thus modify micro-
vascular permeability in human PMVEC.30
We also observed that pretreatment of endothe-
lial cells with PDTC or Sper-NO significantly
inhibited HL-60 adhesion to TNF-a-stimulated cells,
which corresponded to the functional significanceof the inhibition of E-selectin induction by these
chemicals.
After the completion of this work, we found that
both cell surface and mRNA expression of adhesion
molecules (E-selectin, ICAM-1, VCAM-1) in human
dermal microvascular endothelial cells induced by
TNF-a ere inhibited significantly by pretreatment
with PDTC or Sper-NO, possibly via blocking redox-
regulated NF-kB activation.37 These results are
consistent with the findings of the present work,
and provide some evidence that the redox-sensitive
NF-kB activation is essential for TNF-a-induced cell
adhesion molecule upregulation in human micro-
vascular endothelial cells.
In summary, triggering of the pulmonary vascular
inflammatory response by TNF-a via upregulation of
cell adhesion molecules appears to require ROI and
to be attenuated by PDTC or Sper-NO. Although our
in vitro results cannot be directly extrapolated to
the in vivo situation, they suggest a potentially
effective approach to intervene with and down-
regulate the biological effects of endothelial–leu-
kocyte adhesion in the pulmonary inflammatory
reaction in vivo.Acknowledgment
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